Current Affairs - Science

Why should I study the current affairs questions and answers section on "Science" daily?

Read the daily current affairs questions and answers section on "Science" to enhance your general knowledge for clearing competitive examinations and placement interviews.

Where can I get the current affairs questions and answers section on "Science"?

IndiaBIX provides you with daily current affairs questions and answers with explanations.

Where can I get the current affairs MCQ questions and answers section on "Science" (objective type, multiple choice)?

Here you can find multiple-choice-type current affairs questions and answers on "Science" for your interviews and competitive examinations. All the CA questions are arranged in different categories, including date-wise.

How do I download the current affairs questions section on "Science" in PDF format?

You can download the current affairs quiz questions and answers section on "Science" as PDF files or eBooks.

How do I answer the current affairs quiz section on "Science"?

You can answer any current affairs quiz question on "Science" by reading this current affairs section daily.

Exercise : Science - Latest Current Affairs
  • Science - Latest Current Affairs
1.
Into how many regional languages will Ayurveda research materials be translated under the CCRAS and Anuvadini AI partnership?
13
10
15
8
Answer: Option
Explanation:
The collaboration between the Central Council for Research in Ayurvedic Sciences (CCRAS) and Anuvadini AI focuses on making Ayurveda research widely accessible by translating it into multiple regional languages. The initiative specifically targets 13 languages, including Hindi, to ensure that valuable scientific and educational content reaches a broader audience across India. This effort helps bridge linguistic barriers, making traditional medical knowledge more inclusive and understandable. By leveraging artificial intelligence, the program enhances the dissemination of authentic information, supports regional outreach, and reduces misinformation, especially in rural and linguistically diverse populations.

2.
Which disease is the focus of the collaborative clinical study announced by the Ministry of Ayush and DBT using Ayurveda as an adjunct therapy?
Tuberculosis
Malaria
Dengue
Diabetes
Answer: Option
Explanation:
The collaborative clinical study launched by the Ministry of Ayush and the Department of Biotechnology focuses on Tuberculosis, aiming to integrate Ayurveda with standard Anti-Tuberculosis Treatment. This approach seeks to enhance recovery outcomes, improve nutrition, and elevate the quality of life for patients. A major focus is on managing TB-related cachexia, a condition involving severe weight and muscle loss. Conducted over a 24-month period across leading medical institutions such as AIIMS and JIPMER, the study reflects a scientific effort to validate traditional medicine through evidence-based research and promote holistic healthcare solutions.

3.
Which company has launched an affordable Semaglutide injection in India using an innovative multi-dose pen?
Cipla
Sun Pharma
Zydus
Dr Reddy’s Laboratories
Answer: Option
Explanation:
Zydus has introduced an affordable Semaglutide injection in India, targeting the treatment of Type 2 Diabetes Mellitus and obesity. The innovation includes a reusable multi-dose pen, allowing patients to adjust dosages conveniently from a single device, unlike traditional single-use pens. This significantly improves ease of use and reduces treatment costs, with an average monthly expense of around ₹2,200. Manufactured at the Zydus Biotech Park in Ahmedabad, the product aims to make GLP-1 therapies more accessible, especially in a country facing a growing burden of diabetes and rising obesity rates.

4.
Which Indian state has launched a statewide Foot and Mouth Disease vaccination drive under the National Animal Disease Control Programme?
Maharashtra
Gujarat
Rajasthan
Punjab
Answer: Option
Explanation:
Gujarat has initiated a large-scale Foot and Mouth Disease (FMD) vaccination drive to protect livestock and prevent the spread of this highly contagious viral infection. The campaign is being conducted under the National Animal Disease Control Programme (NADCP) and runs from March 1 to April 15. It targets animals such as cattle, buffalo, sheep, and goats, which are highly vulnerable to the disease. Veterinary teams are actively visiting villages and farms to administer vaccines and monitor animal health. The initiative also uses digital tools like the INAPH portal to track vaccination coverage and ensure effective disease control.

5.
Which company received regulatory approval in China for the anaemia drug Desidustat?
Sun Pharma
Dr Reddy’s Laboratories
Zydus Lifesciences
Cipla
Answer: Option
Explanation:
Zydus Lifesciences secured regulatory approval from China’s National Medical Products Administration for its innovative drug Desidustat, used to treat renal anaemia in chronic kidney disease patients. The drug functions as a HIF-PHI inhibitor, stimulating red blood cell production and improving iron metabolism. It has already shown strong clinical efficacy in Phase III trials conducted in China. The approval is significant due to China’s large CKD patient population. Additionally, the drug has been successfully marketed in India under the brand Oxemia, benefiting over 100,000 patients since its launch in 2022, highlighting its therapeutic effectiveness and commercial potential.